During the past decade, UMDNJ - New Jersey Med School / Cooper Hosp conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMDNJ - New Jersey Med School / Cooper Hosp" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Washington University School of Medicine" with 2 trials sponsored, "InterMune" with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "Schering-Plough" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UMDNJ - New Jersey Med School / Cooper Hosp" #1 collaborator was "Cooper University Health Care" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "University of Iowa" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UMDNJ - New Jersey Med School / Cooper Hosp" are "HIV Infections" (5 trials), "Mechanical Ventilation" (2 trials), "Awareness" (1 trials), "Candidiasis, Oral" (1 trials) and "Intubation Complication" (1 trials). Many other conditions were trialed in "UMDNJ - New Jersey Med School / Cooper Hosp" in a lesser frequency.

Most popular intervention types in "UMDNJ - New Jersey Med School / Cooper Hosp" are "Drug" (5 trials), "Behavioral" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Education" (2 trials), "Fluconazole" (2 trials), "Saquinavir" (2 trials), "Amphotericin B" (1 trials) and "Clarithromycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMDNJ - New Jersey Med School / Cooper Hosp" are 7 trials for "All" genders.

Currently, there are NaN active trials in "UMDNJ - New Jersey Med School / Cooper Hosp". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in UMDNJ - New Jersey Med School / Cooper Hosp, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UMDNJ - New Jersey Med School / Cooper Hosp, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".